Reducing Unnecessary Care for Traumatic Injury
Trial Summary
What is the purpose of this trial?
In Canada, injury leads to more potential years of life lost and to greater costs than heart and stroke diseases combined. Furthermore, more than 50% of patients hospitalised following injury do not receive optimal care, 20% of injury deaths are estimated to be preventable, and significant variations in injury mortality and morbidity have been observed across trauma centers in Canada, the United Kingdom, Australia and the United States. Over the past decades, emphasis on adherence to evidence-based processes of care (rewards for doing more) and rapid innovation in imaging and therapeutic techniques has led to an exponential rise in unnecessary tests and procedures. Whole body computed tomography scan for single-system trauma is just one example. Low-value clinical practices, defined as "the common use of a particular intervention when the benefits don't justify the potential harm or cost" consume up to 30% of healthcare budgets. They expose patients to physical and psychological adverse events and put enormous pressure on healthcare budgets, thereby threatening accessible, universal health care. The objective of this research project is to evaluate the effectiveness of an intervention targeting reductions in low-value clinical practices for injury admissions. The results of this study should directly lead to improvements in the health systems across Canada and elsewhere. Medium and long-term advantages include an increase in healthcare efficiency and effectiveness, a reduction in costs, an increase in the availability of resources for patients who need them and a reduction in adverse events for patients hospitalized following injury.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of this treatment?
Is the treatment generally safe for humans?
The research articles do not provide specific safety data for the treatment 'Reducing Unnecessary Care for Traumatic Injury' or its related interventions. They focus on monitoring adverse events and improving surgical safety, but do not directly address the safety of the treatment in question.678910
How does this treatment for traumatic injury differ from other treatments?
This treatment is unique because it focuses on reducing unnecessary care through a multifaceted intervention, which includes quality improvement teams and performance-linked accreditation, rather than relying solely on traditional medical interventions. It aims to de-implement low-value clinical practices in trauma care, which is different from standard treatments that primarily focus on direct medical interventions.211121314
Eligibility Criteria
This trial is for adult trauma centers in Québec's Trauma Care Continuum, specifically levels I-III. It aims to improve care for patients hospitalized with injuries by reducing unnecessary medical procedures. Level IV centers are excluded due to low patient volumes.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention Implementation
Implementation of the multifaceted intervention including audit & feedback, educational materials, and virtual facilitation visits
Follow-up
Participants are monitored for the effectiveness of the intervention in reducing low-value care practices
Evaluation
Evaluation of primary and secondary outcomes including low-value imaging and specialist consultations
Treatment Details
Interventions
- Audit & feedback with educational outreach and facilitation
- Simple audit & feedback (usual practice)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Laval University
Lead Sponsor
Trauma Association of Canada
Collaborator
Health Standards Organisation
Collaborator
Audit & Feedback Metalab
Collaborator
Institut national de la pertinence des actes médicaux
Collaborator
Institut national en santé et services sociaux
Collaborator
Choosing Wisely Canada
Collaborator